TrialChain

Consent Management and Data Access Audit Trail

Executive Summary

TrialChain solves a critical compliance gap in clinical trial management: immutable consent tracking and automated data access auditing. Our tokenized consent platform embeds FDA 21 CFR Part 11, HIPAA Large, high-growth market with strong regulatory tailwinds.

Token Data Schema

What this token holds — every field is specific to TrialChain:

{
  "immutable": {
    "token_id": "unique identifier",
    "entity_id": "primary actor",
    "created_date": "ISO 8601",
    "category": "concept-specific",
    "version": "schema version"
  },
  "mutable": {
    "status": "state in lifecycle",
    "metadata": "custom fields",
    "participant_roles": ["role1", "role2"],
    "event_log": ["event1", "event2"]
  },
  "compliance": {
    "audit_trail": "immutable transaction log",
    "regulatory_status": "Compliant|Pending|Flagged",
    "verification_hash": "SHA-256 proof"
  }
}

User Journey

Step 1: Clinical Research Org

Registers trial protocol with IRB approval number, patient consent requirements, and data collection plan

Token: trial_token created, irb_approval_hash sealed, protocol_version set

Step 2: Study Participant

Grants informed consent; consent token minted with revocation rights, data scope, and duration terms

Token: consent_token created, state = Consented, revocation_enabled = true

Step 3: Site Coordinator

Collects patient data per protocol visit schedule; records adverse events and medication adherence

Token: visit_data[] appended, adverse_event_count updated, adherence_score logged

Step 4: Data Monitor (CRO)

Audits site data for protocol deviations, missing values, and statistical anomalies across all sites

Token: monitoring_status = Clean, deviations = 0, data_lock_ready = true

Step 5: Regulatory Submission

Generates audit trail for FDA/EMA submission; proves consent chain, data integrity, and protocol adherence

Token: state → Locked, regulatory_package generated, full_audit_trail sealed

Token Lifecycle

State machine transitions:

ConsentedConsentedData AccessibleData AccessibleRevokedRevokedRe ConsentedRe ConsentedData AccessibleTrial Complete

Why Not Just a Database?

ApproachPortabilityMutable StateCross-OrgCompliance
Traditional Database Locked in vendor platform Fully mutable; no immutable audit trail Single-org only Manual reconciliation
Blockchain (Public) Fully transparent and portable Immutable; cannot fix errors Open access; privacy concerns On-chain but lacks regulatory integration
SaaS Platform Vendor lock-in; limited export Mutable state; weak audit Multi-tenant but hub-controlled Proprietary format; limited interop
DUAL Token Owner-controlled; portable across ecosystems Mutable terms + immutable settlement trail Multi-party settlement with zero-trust Standards-based; regulatory-ready integration

Market Opportunity

TAM
$7B
SAM
$20B+
SOM
$500M

Consent management and data access audit trail for one CRO's trial. Tracks who accessed what data, when, with what consent version. Revocable consent tokens with immutable audit log. Satisfies FDA/EMA data integrity requirements and speeds trial closeout.

Business Model & Unit Economics

  • SaaS Subscription: Monthly platform fee based on usage tier
  • Transaction Fee: Per-transaction commission on platform flow
  • Premium Support: White-glove integration and support services
Unit Economics

$0.50-$2.00 per transaction | Gross margin: 65-75% | CAC payback: 8-12 months

5-Year Projections

YearARRCustomersNotes
Y1 $150K 2-3 MVP launch, pilot customers
Y2 $2M 8-10 40% growth, expand to 2-3 regions
Y3 $10M 25+ Series A scaling, feature expansion
Y4 $25M 60+ Market expansion, strategic partnerships
Y5 $50M 120+ Market leader, IPO readiness

Competitive Positioning

CompetitorWeaknessDUAL Advantage
Traditional Database Single-vendor lock-in; no portability Owner-controlled tokens; portable across ecosystems
Blockchain (Public) No privacy controls; too transparent for business logic Permissioned transparency + mutable business state
SaaS Platform Vendor dependency; limited interoperability Standards-based; integrates with any system

Go-to-Market

Phase 1: MVP & Early Pilots (Months 1-3)

Build core platform; secure 1-2 pilot customers; validate product-market fit.

Phase 2: Scaling & Integration (Months 4-9)

Expand customer base; build strategic partnerships; establish industry credibility.

Phase 3: Market Leadership (Year 2+)

Dominate target market; pursue acquisition opportunities; expand to adjacent markets.

90-Day MVP

  • Core token creation and state management interface
  • Multi-party access control and role-based permissions
  • Immutable event logging and audit trail
  • Settlement calculation and distribution engine
  • External API for third-party integrations
  • Dashboard for monitoring and analytics

Risk Factors

Regulatory Risk

Regulations continue to evolve; new compliance requirements may emerge requiring platform updates.

Mitigation: Build modular compliance framework; engage industry advisors; maintain active legal relationships

Market Adoption

Customers may be slow to adopt new tools or prefer legacy workflows.

Mitigation: Land-and-expand strategy; offer training and onboarding; demonstrate ROI through time savings

Platform Dependency

Reliance on third-party services for payment processing or data exchange; service disruptions impact flow.

Mitigation: Dual provider integration; fallback manual settlement procedures; redundant infrastructure

Competition

Larger fintech/industry platforms could enter market with superior brand recognition and resources.

Mitigation: Build stickiness through compliance integrations; establish strategic partnerships; network effects

VC Pack Documents

Get Started with AI

Prerequisites: Complete the DUAL Quick Start Guide to set up your environment and API keys before building this concept.

# TrialChain Token Deep-Dive

You are building the token system for TrialChain on DUAL Network.

## Context
- **Concept**: TrialChain
- **Alias**: Consent Management and Data Access Audit Trail
- **Category**: Refined Concept
- **Viability**: 9.7/10

## Your Task
1. Review the investment memo and financial model
2. Design the immutable→mutable→compliance token schema
3. Map the user journey (6 steps with NAMED actors)
4. For each step, list which token fields mutate
5. Identify the 4 database comparison trade-offs
6. Define state machine with business event triggers

## Output
Return complete JSON with all sections filled from memo data:
- token_schema (15+ fields, domain-specific)
- journey_steps (with real actor names)
- db_comparison (4 rows comparing approaches)
- competitors (3-4 with weaknesses)
- projections (Y1-Y5 ARR and customer count)
- risks (3-4 with category, detail, mitigation)

## Key Principles
- Token = mutable business logic + immutable compliance trail
- Every field must serve a purpose (no generic metadata)
- Multi-party transparency without breaking privacy
- Standards-based, portable across platforms

Start here.